Global In Vitro Diagnostics (IVD) Market Report: 2013 Edition
The process of performing a diagnostic test outside of a living organism in an artificial environment, usually a laboratory, is called in-vitro diagnostic (IVD). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Further, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run.
A consistent increase has been observed in the global IVD industry over the past couple of years. Even in 2009, the IVD industry was unaffected by the economic and financial turmoil thereby proving the industry as recession proof. On the basis of technology, central lab immunoassay strongly dominated the IVD market followed by whole body glucose and clinical chemistry. Further, in case of IVD sale by test location, the market was led by testing at central labs, followed by point-of-care testing.
The key factors driving growth of the global IVD industry include rising global healthcare expenditure, increasing aging population, accelerating global diabetic population apart from rising incidences of chronic and infectious diseases. Some of the noteworthy trends and developments of this industry include increasing demand for early diagnosis, expansion of point of care testing and growth of minimally invasive and non-invasive procedures. However, the growth of IVD industry is hindered by the strict regulatory compliance imposed on manufacturers.
The report contains a comprehensive analysis of the global IVD industry along with the study of regional markets including Europe, Brazil and China. An intense competition is noted among few major players; Roche, Abbott, Siemens, J&J and Danaher. Apart from global competitive analysis, regional competitive landscape is also included in the report along with company profiles of the leading players in the market.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
A consistent increase has been observed in the global IVD industry over the past couple of years. Even in 2009, the IVD industry was unaffected by the economic and financial turmoil thereby proving the industry as recession proof. On the basis of technology, central lab immunoassay strongly dominated the IVD market followed by whole body glucose and clinical chemistry. Further, in case of IVD sale by test location, the market was led by testing at central labs, followed by point-of-care testing.
The key factors driving growth of the global IVD industry include rising global healthcare expenditure, increasing aging population, accelerating global diabetic population apart from rising incidences of chronic and infectious diseases. Some of the noteworthy trends and developments of this industry include increasing demand for early diagnosis, expansion of point of care testing and growth of minimally invasive and non-invasive procedures. However, the growth of IVD industry is hindered by the strict regulatory compliance imposed on manufacturers.
The report contains a comprehensive analysis of the global IVD industry along with the study of regional markets including Europe, Brazil and China. An intense competition is noted among few major players; Roche, Abbott, Siemens, J&J and Danaher. Apart from global competitive analysis, regional competitive landscape is also included in the report along with company profiles of the leading players in the market.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. OVERVIEW
1.1 Types of IVD Products
1.2 Types of IVDs
1.3 Market Segments
1.3.1 Technology Segmentation
1.3.2 End-User Segmentation
1.4 Uses of IVDs
1.5 IVD Value Chain
2. IVD MARKET ANALYSIS
2.1 Global IVD Market
Market Value
Key Players
2.2 Market Segmentation
Major Segments
Segment Share
Growth of Segments
2.3 Regional Analysis
Major Markets
Regional Share
2.3.1 European Union
Market Value
Market Value by Countries
Other Statistics by Countries
2.3.2 China
Market Overview
Market Value
2.3.3 Brazil
Market Overview
Market Value
3. MARKET DYNAMICS
3.1 Growth Drivers
3.1.1 Rising Global Healthcare Expense
3.1.2 Increasing Global Aging Population
3.1.3 Accelerating Global Diabetic Population
3.1.4 Rising Incidences of Chronic and Infectious Diseases
3.1.5 Increasing Global Gross National Income
3.2 Key Trends
3.2.1 Increasing Demand for Early Diagnosis
3.2.2 Continued Expansion of Point of Care Testing
3.3 Challenges
3.3.1 Strict Regulatory Compliance
4. COMPETITIVE LANDSCAPE
4.1 Global Market
4.2 Regional Markets
4.2.1 Brazil
4.2.2 China
4.3 Competition by IVD Market Segments
4.3.1 Immunoassays Segment
4.3.2 Molecular Biology Segment
4.3.3 Microbiology Segment
4.4 Competition by Company Performance
4.4.1 IVD Revenues
4.4.2 Reported Growth
4.4.3 Organic Growth
5. COMPANY PROFILES
5.1 Roche Holdings AG
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on R&D
Strategic Collaborations
5.2 Siemens AG
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Focus on R&D Activities
Global Expansion
5.3 Abbott Laboratories
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Ameliorating Product Line
Expansion through Acquisitions
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
1.1 Types of IVD Products
1.2 Types of IVDs
1.3 Market Segments
1.3.1 Technology Segmentation
1.3.2 End-User Segmentation
1.4 Uses of IVDs
1.5 IVD Value Chain
2. IVD MARKET ANALYSIS
2.1 Global IVD Market
Market Value
Key Players
2.2 Market Segmentation
Major Segments
Segment Share
Growth of Segments
2.3 Regional Analysis
Major Markets
Regional Share
2.3.1 European Union
Market Value
Market Value by Countries
Other Statistics by Countries
2.3.2 China
Market Overview
Market Value
2.3.3 Brazil
Market Overview
Market Value
3. MARKET DYNAMICS
3.1 Growth Drivers
3.1.1 Rising Global Healthcare Expense
3.1.2 Increasing Global Aging Population
3.1.3 Accelerating Global Diabetic Population
3.1.4 Rising Incidences of Chronic and Infectious Diseases
3.1.5 Increasing Global Gross National Income
3.2 Key Trends
3.2.1 Increasing Demand for Early Diagnosis
3.2.2 Continued Expansion of Point of Care Testing
3.3 Challenges
3.3.1 Strict Regulatory Compliance
4. COMPETITIVE LANDSCAPE
4.1 Global Market
4.2 Regional Markets
4.2.1 Brazil
4.2.2 China
4.3 Competition by IVD Market Segments
4.3.1 Immunoassays Segment
4.3.2 Molecular Biology Segment
4.3.3 Microbiology Segment
4.4 Competition by Company Performance
4.4.1 IVD Revenues
4.4.2 Reported Growth
4.4.3 Organic Growth
5. COMPANY PROFILES
5.1 Roche Holdings AG
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on R&D
Strategic Collaborations
5.2 Siemens AG
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Focus on R&D Activities
Global Expansion
5.3 Abbott Laboratories
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Ameliorating Product Line
Expansion through Acquisitions
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
LIST OF CHARTS
IVD Market Segments by Technology
IVD Market by End Users
IVD Value Chain Analysis in Medical Application
Global IVD Market (2007-2012)
IVD Market by Test Location (2012)
Percentage Share of IVD Market by Test Location (2012)
Percentage Share of Segments of Global IVD Market (2012)
Growth of Segments of Global IVD Market (2011/2012)
Global IVD Market by Region (2012)
Regional Share in Global IVD Market (2012)
IVD Market in the Europe (2007-2012)
IVD Market in Europe – by Countries (2012)
IVD Market Share in Europe – by Countries (2012)
China’s In-Vitro Diagnostic Reagent Market Size (2007-2013E)
China’s In-Vitro Diagnostic Reagent Y-o-Y Growth Rate (2008-2013E)
Brazil IVD Market Revenues (2003-2012)
Global Health Care Expenditure Per Capita (2008-2012)
Global Aging Population (Over 65) as a Percentage of Total Population (2008-2012)
World Population with Diabetes, Age Group 20-79 years (2006-2013)
World Gross National Income (2008-2012)
Global IVD Market – Share Breakdown by Company (2012)
Market Share of IVD Players in Brazil (2012)
Market Share of IVD Players in China (2012)
Immunoassays Market Share (2012)
Molecular Biology Market Share (2012)
Microbiology Market Share (2012)
Roche’s Revenue by Business Segments (2012)
Roche Holding’s Revenue and Net Income (2008-2012)
Siemens AG’s Revenue by Business Segments (2013)
Siemens AG’s Revenues and Net Income (2008-2013)
Abbott Laboratories Revenue by Business Segment (2012)
Abbott Laboratories Revenue and Net Earnings (2008-2012)
Global In Vitro Diagnostics Market (2007-2016F)
IVD Market Segments by Technology
IVD Market by End Users
IVD Value Chain Analysis in Medical Application
Global IVD Market (2007-2012)
IVD Market by Test Location (2012)
Percentage Share of IVD Market by Test Location (2012)
Percentage Share of Segments of Global IVD Market (2012)
Growth of Segments of Global IVD Market (2011/2012)
Global IVD Market by Region (2012)
Regional Share in Global IVD Market (2012)
IVD Market in the Europe (2007-2012)
IVD Market in Europe – by Countries (2012)
IVD Market Share in Europe – by Countries (2012)
China’s In-Vitro Diagnostic Reagent Market Size (2007-2013E)
China’s In-Vitro Diagnostic Reagent Y-o-Y Growth Rate (2008-2013E)
Brazil IVD Market Revenues (2003-2012)
Global Health Care Expenditure Per Capita (2008-2012)
Global Aging Population (Over 65) as a Percentage of Total Population (2008-2012)
World Population with Diabetes, Age Group 20-79 years (2006-2013)
World Gross National Income (2008-2012)
Global IVD Market – Share Breakdown by Company (2012)
Market Share of IVD Players in Brazil (2012)
Market Share of IVD Players in China (2012)
Immunoassays Market Share (2012)
Molecular Biology Market Share (2012)
Microbiology Market Share (2012)
Roche’s Revenue by Business Segments (2012)
Roche Holding’s Revenue and Net Income (2008-2012)
Siemens AG’s Revenue by Business Segments (2013)
Siemens AG’s Revenues and Net Income (2008-2013)
Abbott Laboratories Revenue by Business Segment (2012)
Abbott Laboratories Revenue and Net Earnings (2008-2012)
Global In Vitro Diagnostics Market (2007-2016F)
LIST OF TABLES
IVD Market Key Players-by Segments
Segments of Global IVD Market (2012)
Country-wise Division of European IVD Market (2012)
Global In-Vitro Diagnostic Sales of Market Players (Q112-Q113)
Reported Growth of IVD Players (Q112-Q113)
Ex-FX/ Organic Growth of IVD Players (Q112-Q113)
Dependent & Independent Variables (2006–2011)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
IVD Market Key Players-by Segments
Segments of Global IVD Market (2012)
Country-wise Division of European IVD Market (2012)
Global In-Vitro Diagnostic Sales of Market Players (Q112-Q113)
Reported Growth of IVD Players (Q112-Q113)
Ex-FX/ Organic Growth of IVD Players (Q112-Q113)
Dependent & Independent Variables (2006–2011)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
